Pfizer-BioNTech, Moderna COVID-19 vaccines approved by US FDA

Robert Besser
17 Sep 2023, 07:30 GMT+10

The U.S. FDA-approved the updated COVID-19 vaccines from Pfizer-BioNTech and Moderna for launch later this week for the fall vaccination campaign
The FDA approved the two shots for people aged 12 and above and for emergency use in children aged six months to 11 years
Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 sub-variant of the virus, will be available for most people in the U.S. in the coming days

SILVER SPRING, Maryland: This week, the U.S. Food and Drug Administration (FDA) approved the updated COVID-19 vaccines from Pfizer-BioNTech and Moderna for launch later this week for the fall vaccination campaign, while a third vaccine made by Novavax is still under review.

The FDA approved the two shots for people aged 12 and above and for emergency use in children aged six months to 11 years.

Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 sub-variant of the virus, will be available for most people in the U.S. in the coming days.

In a statement, leading FDA scientist Dr. Peter Marks said, "The public can be assured that these updated vaccines have met the agency's rigorous scientific standards for safety, effectiveness, and manufacturing quality. We very much encourage those who are eligible to consider getting vaccinated."

Mandy Cohen, director of the Centers for Disease Control and Prevention (CDC), said she expects the new shots to roll out in September.

The approval by the FDA follows a recent rise in cases of the new EG.5 sub-variant of Omicron, nicknamed "Eris," which has begun to spread rapidly in the U.S. and other countries.

Scientists also have raised concerns about the highly mutated BA.2.86 sub-variant, detected in several countries.

Last week, Pfizer and Moderna said that their updated COVID-19 vaccines generated strong responses in testing against BA.2.86.

After the U.S. government ended its COVID-19 public health emergency status in May and handed over the responsibility for vaccinations to the private sector, demand for the vaccine has dropped sharply.

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Japan Herald.

More Information

23 ℃

Light Rain in Shinagawa City

Asia Pacific

Section

South Korean teachers seek legal defense against abusive parents

SEOUL, South Korea: Thousands of South Korean educators and school staff gathered in Seoul over the weekend to demand increased ...

Tragedy of 2019 Christchurch attacks remembered

CHRISTCHURCH, New Zealand In a heartfelt tribute to the victims of the tragic 2019 Christchurch attacks, the Australian Federal Police ...

Indonesian imports declined more than expected, shows government data

JAKARTA, INDONESIA: Government data released this week showed that as imports, such as raw materials and capital goods, declined more ...

Gas exports from Chevron Australia continue, despite outage, strikes

SYDNEY, Australia: Contrary to earlier concerns, exports of liquefied natural gas (LNG) continued from Chevron's two Western Australian plants last ...

Foxconn founder picks actress as VP choice in Taiwan presidential poll

TAIPEI, Taiwan: This week, Terry Gou, founder of major Apple supplier Foxconn, announced that his running mate in Taiwan's presidential ...

Northrop Grumman, Lockheed sanctioned by China for sales to Taiwan

BEIJING, China: U.S. aerospace and defense firms Northrop Grumman and Lockheed Martin have been sanctioned by China for selling weapons ...

Business

Section